Ascent Solar Technologies, Inc. Announces Second and Third Closings of Public Offering of Common Stock and Pre-Funded Warrants at $0.14 Per Share
April 18, 2024 17:11 ET
|
Ascent Solar Technologies, Inc.
THORNTON, Colo., April 18, 2024 (GLOBE NEWSWIRE) -- Ascent Solar Technologies, Inc. (“Ascent Solar” or the “Company”) (NASDAQ: ASTI), a U.S. innovator in the design and manufacturing of...
Peloton Interactive, Inc. Announces Third Quarter Fiscal 2024 Earnings Release Date, Conference Call, and Webcast
April 18, 2024 17:00 ET
|
Peloton Interactive
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. (NASDAQ: PTON) will release its third quarter fiscal 2024 results before the U.S. stock market opens on Thursday, May 2, 2024....
SurgePays to Participate in Water Tower Fireside Chat Series
April 18, 2024 16:55 ET
|
SurgePays, Inc.
BARTLETT, Tenn., April 18, 2024 (GLOBE NEWSWIRE) -- SurgePays, Inc. (Nasdaq: SURG) (“SurgePays” or the “Company”), a technology and telecom company focused on the underbanked and underserved, today...
Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024
April 18, 2024 16:30 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation...
MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference
April 18, 2024 16:30 ET
|
MeiraGTx
LONDON and NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced the Company gave...
Celularity Abstract “Emerging Technologies for the Management and Protection of Tendon Injuries: Decellularized Placental Biomaterials” Accepted at ORS Tendon Conference 2024
April 18, 2024 16:30 ET
|
Celularity Inc.
FLORHAM PARK, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative medicine company developing placental-derived allogeneic cell therapies and...
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
April 18, 2024 16:30 ET
|
Inhibikase Therapeutics
BOSTON and ATLANTA, April 18, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase...
Malibu Boats, Inc. Announces Earnings Release Date and Conference Call Information for Third Quarter Fiscal 2024 Financial Results
April 18, 2024 16:30 ET
|
Malibu Boats, Inc.
LOUDON, Tenn., April 18, 2024 (GLOBE NEWSWIRE) -- Malibu Boats, Inc. (Nasdaq: MBUU) announced today that it will release its third quarter fiscal 2024 financial results on Thursday, May 2, 2024,...
OneWater Marine Inc. Announces Fiscal Second Quarter 2024 Earnings Release Date and Conference Call Information
April 18, 2024 16:30 ET
|
OneWater Marine Inc.
BUFORD, Ga., April 18, 2024 (GLOBE NEWSWIRE) -- OneWater Marine Inc. (NASDAQ: ONEW) (the “Company” or “OneWater”) announced today that it will release its second quarter 2024 financial results on...
Turbo Energy Announces Financial Results for Year Ended December 31, 2023
April 18, 2024 16:30 ET
|
Turbo Energy S.A.
Valencia, Spain, April 18, 2024 (GLOBE NEWSWIRE) -- Turbo Energy, S.A. (NASDAQ: TURB), a leading energy-saving technology company leveraging artificial intelligence software, today announced that...